Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $21.54 USD
Change Today +0.22 / 1.03%
Volume 1.6M
BMR On Other Exchanges
Symbol
Exchange
New York
Frankfurt
As of 6:40 PM 07/31/15 All times are local (Market data is delayed by at least 15 minutes).

biomed realty trust inc (BMR) Snapshot

Open
$21.51
Previous Close
$21.32
Day High
$21.75
Day Low
$21.43
52 Week High
01/27/15 - $25.11
52 Week Low
07/1/15 - $19.12
Market Cap
4.4B
Average Volume 10 Days
1.4M
EPS TTM
$1.21
Shares Outstanding
203.6M
EX-Date
06/26/15
P/E TM
17.8x
Dividend
$1.04
Dividend Yield
6.17%
Current Stock Chart for BIOMED REALTY TRUST INC (BMR)

Related News

No related news articles were found.

biomed realty trust inc (BMR) Related Businessweek News

No Related Businessweek News Found

biomed realty trust inc (BMR) Details

BioMed Realty Trust, Inc. operates as a real estate investment trust (REIT) that focuses on providing real estate to the life science industry in the United States. Its tenants primarily include biotechnology and pharmaceutical companies, scientific research institutions, government agencies, and other entities involved in the life science industry. The company owns or has interests in 72 properties, representing 119 buildings with approximately 11.0 million rentable square feet. Its properties are located predominantly in the major U.S. life science markets of Boston, San Diego, San Francisco, Seattle, Maryland, Pennsylvania, and New York/New Jersey. The company qualifies as a REIT for federal income tax purposes. It would not be subject to federal corporate income taxes if it distributes at least 90% of its taxable income to its stockholders. BioMed Realty Trust was founded in 2004 and is based in San Diego, California.

247 Employees
Last Reported Date: 02/6/15
Founded in 2004

biomed realty trust inc (BMR) Top Compensated Officers

Co-Founder, Chairman, Chief Executive Officer...
Total Annual Compensation: $760.0K
Co-Founder, Executive Vice President and Dire...
Total Annual Compensation: $125.0K
Chief Financial Officer
Total Annual Compensation: $420.0K
Compensation as of Fiscal Year 2014.

biomed realty trust inc (BMR) Key Developments

BioMed Realty To Sell 65 West Watkins

BioMed Realty Trust Inc. (NYSE:BMR) has put property at 65 West Watkins Mill Road up for sale. The sale is expected to close in the third quarter of 2015.

BioMed Realty Trust Inc. Announces Unaudited Consolidated Financial Results for the Second Quarter and Six Months Ended June 30, 2015; Reports Impairment Loss for the Second Quarter of 2015; Provides Earnings Guidance for the Year 2015

BioMed Realty Trust Inc. announced unaudited consolidated financial results for the second quarter and six months ended June 30, 2015. For the quarter, the company’s total revenues were $157,974,000 compared to $171,161,000 a year ago. Income from operations was $27,801,000 compared to $41,212,000 a year ago. Net income was $37,575,000 compared to $19,098,000 a year ago. Net income attributable to the company was $23,578,000 compared to $18,636,000 a year ago. Basic and diluted net income per share attributable to common stockholders was $0.11 compared to $0.10 for the same period a year ago. Diluted FFO available to common shares and units was $120,811,000 or $0.58 per share compared to $83,378,000 or $0.40 per share a year ago. AFFO available to common shares and units was $100,218,000 or $0.48 per share compared to $67,741,000 or $0.84 per share a year ago. Diluted CFFO available to common shares and units was $121,911,000 or $0.58 per share compared to $84,512,000 or $0.40 per share a year ago. For the six month, the company’s total revenues were $335,984,000 compared to $340,037,000 a year ago. Income from operations was $56,940,000 compared to $81,964,000 a year ago. Net income was $58,356,000 compared to $39,865,000 a year ago. Net income attributable to the company was $40,923,000 compared to $37,469,000 a year ago. Basic and diluted net income per share attributable to common stockholders was $0.20 compared to $0.19 for the same period a year ago. Diluted FFO available to common shares and units was $206,070,000 or $0.99 per share compared to $166,760,000 or $0.81 per share a year ago. AFFO available to common shares and units was $175,992,000 or $0.84 per diluted share compared to $147,493,000 or $0.71 per diluted share a year ago. Diluted CFFO available to common shares and units was $207,634,000 or $0.99 per share compared to $169,144,000 or $0.80 per share a year ago. In the quarter, the company recorded an impairment loss of $35.1 million, primarily as a result of the sale of its King of Prussia property in Radnor, Pennsylvania for approximately $35.2 million in gross proceeds. For the year 2015, the company projected net income per diluted share available to common stockholders between $0.36 to $0.42, FFO per diluted share between $1.74 to $1.80 and project CFFO per diluted share in between $1.75 to $1.81. The company raised full year FFO guidance by $0.13, reflecting $0.02 of additional contribution anticipated from core portfolio based upon continued strong leasing and development execution, and approximately $0.11 in the incremental gains from BioMed Ventures platform. Excluding onetime items, new guidance midpoint of $1.78 per share FFO translates to a normalized midpoint of $1.38 per diluted share for 2015. The company expects real estate depreciation and amortization of $1.21 and impairment of real estate, net of 0.16. The company's 2015 FFO and CFFO estimates reflect the impact of previously announced new investments and dispositions. The foregoing estimates also include the impact of: (i) lease terminations recorded through the six months ended June 30, 2015, aggregating $16.2 million, or $0.08 per diluted share, (ii) investment gains and losses, net of an allocation of income attributable to noncontrolling interests, estimated for the full year 2015 to be approximately $76.7 million, or $0.37 per diluted share, and (iii) the impact of the new development project in Providence, Rhode Island. These estimates also do not include the effect of any other lease termination revenue or investment gains or losses.

BioMed Realty Trust Inc., Q2 2015 Earnings Call, Jul 29, 2015

BioMed Realty Trust Inc., Q2 2015 Earnings Call, Jul 29, 2015

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
BMR:US $21.54 USD +0.22

BMR Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Alexandria Real Estate Equities Inc $92.71 USD +0.11
American Campus Communities Inc $37.32 USD +0.23
Douglas Emmett Inc $29.31 USD +0.11
Equity LifeStyle Properties Inc $57.88 USD +0.43
Home Properties Inc $73.70 USD +0.30
View Industry Companies
 

Industry Analysis

BMR

Industry Average

Valuation BMR Industry Range
Price/Earnings 23.3x
Price/Sales 6.6x
Price/Book 1.4x
Price/Cash Flow 9.6x
TEV/Sales 2.1x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BIOMED REALTY TRUST INC, please visit www.biomedrealty.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.